Surgery Partners (SGRY) Net Income towards Common Stockholders (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 600.0% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.1 million (up 902.48% YoY) and the FY2025 annual result came in at $98.9 million, up 691.2% from the prior year.
• Net Income towards Common Stockholders declined to -$2.1 million in Q1 2026 per SGRY's latest filing, from $29.0 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $57.7 million in Q2 2023, with the low at -$46.6 million in Q4 2024.
• Average Net Income towards Common Stockholders over 5 years is $11.2 million, with a median of $12.2 million recorded in 2022.
• Year-over-year, Net Income towards Common Stockholders slumped 23300.0% in 2022 and surged 1925.0% in 2024.
• Surgery Partners' Net Income towards Common Stockholders stood at -$23.4 million in 2022, then soared by 299.57% to $46.7 million in 2023, then plunged by 199.79% to -$46.6 million in 2024, then surged by 162.23% to $29.0 million in 2025, then tumbled by 107.24% to -$2.1 million in 2026.
• Business Quant data shows SGRY's Net Income towards Common Stockholders at -$2.1 million in Q1 2026, $29.0 million in Q4 2025, and $25.3 million in Q3 2025.